Catalent, Inc.
(NYSE : CTLT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.93%166.030.7%$1112.73m
PFEPfizer Inc. -1.52%48.520.9%$899.70m
LLYEli Lilly & Co. -0.59%314.971.1%$806.13m
MRKMerck & Co., Inc. -0.15%90.910.7%$786.71m
ABBVAbbVie, Inc. -0.86%140.221.9%$785.39m
BMYBristol-Myers Squibb Co. -1.19%73.681.0%$631.07m
SIGASIGA Technologies, Inc. -7.16%23.000.0%$433.56m
AZNAstraZeneca Plc -0.21%66.281.0%$363.29m
GBTGlobal Blood Therapeutics, Inc. 0.18%67.125.6%$345.41m
GSKGSK Plc -0.97%33.980.3%$286.14m
ALNYAlnylam Pharmaceuticals, Inc. 0.07%223.288.2%$270.23m
HZNPHorizon Therapeutics Plc -1.76%60.655.4%$218.20m
CCXIChemoCentryx, Inc. 0.37%50.972.9%$209.16m
KRTXKaruna Therapeutics, Inc. -0.81%259.120.0%$202.59m
VERUVeru, Inc. -20.16%18.990.0%$194.84m

Company Profile

Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment offers formulation, development, and manufacturing services for soft capsules or softgels, as well as large-scale production of oral solid dose forms for pharmaceutical and consumer health markets and supporting ancillary services. The Biologics segment develops and produces biologic cell-line, cell therapy, and viral vector gene therapy, formulation for parenteral dose forms, which include prefilled syringes, vials, and cartridges, and analytical development and testing services for large molecules. The Oral and Specialty Delivery segment consists of advanced formulation of a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment involves packaging, storage, distribution, and inventory management for drugs and biologics in clinical trials. The company was founded in 1933 and is headquartered in Somerset, NJ.